Who is sponsoring NCT03181659?

NCT03181659 is sponsored by Roy La Touche Arbizu.

What condition does NCT03181659 study?

NCT03181659 studies Chronic Nonspecific Low Back Pain, Low Back Pain.

Is NCT03181659 still recruiting?

NCT03181659 is currently status unknown. Last updated 6 September 2018.

Last reviewed 2018-09-06 · How we verify

NCT03181659

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Therapeutic Exercise and Therapeutic Patient Education With or Without Manual Therapy for Chronic Nonspecific Low Back Pain.

Status unknown NA Last updated 6 September 2018

What this trial tests

NA trial testing Manual Therapy, Therapeutic Education, Therapeutic Exercice in Chronic Nonspecific Low Back Pain in 88 participants. Status unknown.

Timeline

1 September 2017

Primary endpoint
29 December 2018

30 May 2019

Quick facts

Lead sponsor	Roy La Touche Arbizu
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	88
Start date	1 September 2017
Primary completion	29 December 2018
Estimated completion	30 May 2019
Sites	1 location across Spain

Drugs / interventions tested

Manual Therapy, Therapeutic Education, Therapeutic Exercice
Therapeutic Education, Therapeutic Exercice

Conditions studied

Chronic Nonspecific Low Back Pain — all drugs for Chronic Nonspecific Low Back Pain →
Low Back Pain — all drugs for Low Back Pain →

Sponsor

Roy La Touche Arbizu

Who can join

18 and older, any sex, with Chronic Nonspecific Low Back Pain or Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial study evaluates the effectiveness of a multimodal physiotherapy treatment based on a biobehavioural paradigm in the treatment of non-specific chronic low back pain. The experimental group received treatment based on therapeutic exercise, education in neuroscience, and manual therapy, contrary to the control group, which did not receive manual therapy treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03181659 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Roy La Touche Arbizu
Last refreshed: 6 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03181659.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing